| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16e10a4c2d6e0903b0b297b2a912f0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df1806cf7b0e593fd0c36b2a3f42e53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33f69e0541c6e0882c5316ad74739256 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-0436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2019-4036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2019-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-049 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2008-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77db8b13a21dad996477e3eeca32ceca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796064de10682d1f063e17dda9ee4e90 |
| publicationDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9149651-B2 |
| titleOfInvention |
Non-invasive vascular treatment systems, devices, and methods of using the same |
| abstract |
An energy treatment system to treat a patient includes an energy delivery device having a plurality of energy emitters used in combination with an energy activatable drug. A mask can be used to define a treatment area. Energy from the energy emitters passes through an optical window of the mask to activate a cosmetically and/or therapeutically effective amount of the activatable drug at the target site to bring about a desired change of tissue, for example, to reduce visibility of one or more blood vessels, while energy from the energy emitters directed outside of the target site is blocked by the mask. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023173299-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11425905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47491-E |
| priorityDate |
2007-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |